Cargando…
Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia
Autores principales: | Bankar, Aniket, Siriwardena, Thirushi Piyumika, Rizoska, Biljana, Rydergård, Christina, Kylefjord, Helen, Rraklli, Vilma, Eneroth, Anders, Pinho, Pedro, Norin, Stefan, Bylund, Johan, Moses, Sara, Bethell, Richard, Kavanagh, Simon, Maclean, Neil, Gronda, Marcela, Wang, Xiaoming, Hurren, Rose, Minden, Mark D., Targett-Adams, Paul, Schimmer, Aaron D., Albertella, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849559/ https://www.ncbi.nlm.nih.gov/pubmed/31857370 http://dx.doi.org/10.3324/haematol.2019.226795 |
Ejemplares similares
-
The thymidine dideoxynucleoside analog, alovudine, inhibits the mitochondrial DNA polymerase γ, impairs oxidative phosphorylation and promotes monocytic differentiation in acute myeloid leukemia
por: Yehudai, Dana, et al.
Publicado: (2019) -
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
por: Jeyaraju, Danny V., et al.
Publicado: (2016) -
Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells
por: Jhas, Bozhena, et al.
Publicado: (2013) -
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism
por: Rotin, Lianne E., et al.
Publicado: (2015) -
A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity
por: Jitkova, Yulia, et al.
Publicado: (2014)